Top videos
Revision Total Knee Replacement part 3
A.K. Venkatachalam
19,889 Views • 2 years ago
Revision knee replacement operation shows trialling after preparation of the bone. For the femur since there is little bone loss,a primary femoral prosthesis is used. For the tibia, a standard tibial base plate is connected to a stem
Brain Cancer Vaccine
Mohamed
10,615 Views • 2 years ago
Source ABC7, 24 November 2009 An initial single-arm Phase II trial (ACT II) has reported promising preliminary data in 23 patients who received CDX-110 vaccine. Median time to disease progression was 16.6 months and estimated median overall survival was 33.1 months. This compared favorably with data for a historical control group in which median time to progression was 6.4 months and median overall survival was 15.2 months. The study was sponsored by Celldex Therapeutics Inc. of Phillipsburg, NJ
Showing 312 out of 378